Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study

por Sun, Haiyan, Ren, Peng, Chen, Yongzi, Lan, Lan, Yan, Zhuchen, Yang, Yinli, Wang, Bin, Wang, Cong, Li, Yanwei, Li, Ling, Zhang, Yu, Li, Yanyang, Wang, Zuolin, Pan, Zhanyu, Jiang, Zhansheng
Publicado 2023